Fig. 5. (A) Concentration-dependent decrease in mean force in response to
adenosine. A statistically significant decrease was obtained at
10
µmol l–1 in prometamorphosis (N=12), at
100
µmol l–1 in metamorphosis (N=6) and at
300
µmol l–1 in juveniles (N=12). (B)
Concentration-dependent decrease in mean force in response to
N6-cyclopentyladenosine (CPA) in prometamorphosis
(N=8), metamorphosis (N=11) and juveniles (N=10).
Statistically significant decrease obtained at
1 µmol
l–1 for all stages. Control value prior to administration of
agonist is denoted C on the x-axis. Statistical analysis was
performed using repeated measures one-way ANOVA followed by Dunnett's post
hoc test (A,B). (C) Effect of adenosine in the presence and absence of
the A1 receptor antagonist DPCPX (1 µmol l–1)
in prometamorphic (100 µmol l–1 adenosine, N=4)
and juvenile (1000 µmol l–1 adenosine, N=9)
stomach muscle strips. Statistical analysis was performed using repeated
measures one-way ANOVA followed by Bonferroni's post hoc test.
Asterisk indicates P<0.05. (D) Effects of the adenosine kinase
inhibitor
4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine
(ABT-702, 1 µmol l–1) on mean force developed under
control conditions in prometamorphic (N=7) and juvenile
(N=10) tissues. Statistical significance was calculated using
Student's t-test for paired observations. Asterisk indicates
P<0.05.